Anti-human TNFRSF10B / TRAILR2 / CD262 (Lexatumumab Biosimilar) Size:1 mg Conjugation None Clone# Bevacizumab Formulation

Conjugation None Clone# Bevacizumab Formulation 100 mM Pro-Ac 20mM Arg pH 5

Studies have shown that elevated MMP9 is associated with progression of idiopathic atrial fibrillation and aortic aneurysm

Conjugation None Clone# Mepolizumab Formulation 100 mM Pro-Ac 20mM Arg pH 5

not for use in human

and its expression is induced by heat shock

Anti-human TNFRSF10B / TRAILR2 / CD262 (Lexatumumab Biosimilar) Size:1 mg Conjugation None Clone# Bevacizumab FormulationApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human, Mouse Target Target Name TNFRSF10B TRAILR2 CD262 Target Uniprot O14763 Overview Catalog# BIO0794SM Product Name Anti human TNFRSF10B TRAILR2 CD262 (Lexatumumab Biosimilar) Specifications Conjugation None Clone# Lexatumumab Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution